Kawasaki disease in Sicily: clinical description and markers of disease severity

Maria Cristina Maggio1, Giovanni Corsello2, Eugenia Prinzi2

  • 1University Department Pro.Sa.M.I. "G. D'Alessandro", University of Palermo, via dei Benedettini n.1, 90134, Palermo, Italy. mariacristina.maggio@unipa.it.

Insights

This study identifies laboratory markers like hypoalbuminemia and elevated D-dimer as predictors of resistant Kawasaki disease (KD). Early pericarditis in KD patients warrants close monitoring for coronary artery lesions.

Area of Science:

  • Pediatrics
  • Rheumatology
  • Cardiology

Background:

  • Kawasaki disease (KD) is a critical vasculitis affecting children, with potential for coronary artery lesions (CAL).
  • Identifying risk factors for resistant KD and CAL is crucial for effective management.
  • This study focuses on a genetically diverse pediatric population in Sicily.

Purpose of the Study:

  • To identify predictive laboratory markers for resistant Kawasaki disease (KD).
  • To analyze risk factors associated with coronary artery lesions (CAL) in KD patients.
  • To evaluate the effectiveness of intravenous immunoglobulin (IVIG) treatment in a Sicilian cohort.

Main Methods:

  • Retrospective analysis of clinical and laboratory data from 70 Sicilian children diagnosed with KD.
  • Echocardiographic assessments were performed at multiple time points post-diagnosis.
  • Demographic, laboratory, and treatment parameters were correlated with disease resistance and CAL.

Main Results:

  • Eighty percent of patients responded to one dose of IVIG; 20% had resistant KD.
  • Hypoalbuminemia, elevated D-dimer, and gamma-GT pre-IVIG correlated with increased IVIG dosage requirements.
  • Cardiac involvement, including aneurysms, was observed in 31% of patients; early pericarditis was linked to coronaritis.

Conclusions:

  • Specific laboratory parameters (hypoalbuminemia, D-dimer, gamma-GT) may predict resistant KD.
  • Early pericarditis in KD patients necessitates vigilant monitoring for CAL.
  • This research provides insights into KD management within the Sicilian population.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
878
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
687
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
870
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
505
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
399
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
687